Anika Therapeutics, Inc. - ANIK

SEC Filings Our ANIK Tweets

About Gravity Analytica

Recent News

  • 08.11.2026 - Support Long-Term Joint Health as You Age
  • 07.29.2026 - Anika Reports Second Quarter 2026 Financial Results
  • 07.29.2026 - Anika Reports Second Quarter 2026 Financial Results
  • 07.15.2026 - Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
  • 07.15.2026 - Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
  • 07.01.2026 - Summer Activities and Foods That Support Joint Health
  • 06.29.2026 - Unexplained Bone Pain? Understanding Insufficiency Fractures and Tactoset
  • 06.09.2026 - Osteoarthritis and Inflammation: Understanding What’s Happening Inside the Joint
  • 06.05.2026 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 05.21.2026 - What Is Cingal? A Proven Joint Injection for Osteoarthritis Pain

Recent Filings

  • 08.07.2026 - 144 Report of proposed sale of securities
  • 08.05.2026 - 4 Statement of changes in beneficial ownership of securities
  • 07.31.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 07.29.2026 - S-8 Securities to be offered to employees in employee benefit plans
  • 07.29.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 07.29.2026 - 8-K Current report
  • 07.29.2026 - EX-99.1 EX-99.1
  • 07.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 07.14.2026 - 8-K Current report
  • 06.23.2026 - 4 Statement of changes in beneficial ownership of securities